Login
$EVH
$4.81 -$0.09 (1.84%) Live

$EVH 8-K SEC Filings

Filed On Filing
05 Nov 2026 8-K: Results of Operations and Financial Condition

WASHINGTON (November 5, 2026) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler...

06 Aug 2026 8-K: Results of Operations and Financial Condition

WASHINGTON (August 6, 2026) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler a...

04 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

(a) Evolent Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) on June 4, 2026. At the 2026 Annual Meeting, the Company’s stockholders voted on four proposals. The proposals are describe...

07 May 2026 8-K: Results of Operations and Financial Condition

WASHINGTON (May 7, 2026) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and ...

24 Feb 2026 8-K: Results of Operations and Financial Condition

WASHINGTON (February 24, 2026) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simple...

08 Dec 2025 8-K: Other Events

On December 5, 2025, Evolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., consummated the transactions contemplated by the previously announced Stock Purchase Agreement, dated September 23, 2025, by and between Evolent ...

02 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

On December 1, 2025, Ms. Cheryl Scott retired from the Board of Directors (the “Board”) of Evolent Health, Inc. (the “Company”). Ms. Scott’s decision to retire was not the result of any disagreement between the Company and Ms. Scott on a...

06 Nov 2025 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

WASHINGTON (November 6, 2025) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler...

23 Sep 2025 8-K: Regulation FD Disclosure; Other Events

WASHINGTON, September 23, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that it has agreed to sell its value-b...

21 Aug 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

INDENTURE dated as of August 21, 2025 between EVOLENT HEALTH, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking associat...

19 Aug 2025 8-K: Other Events

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

18 Aug 2025 8-K: Other Events

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

07 Aug 2025 8-K: Results of Operations and Financial Condition

WASHINGTON (August 7, 2025) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler a...

20 Jun 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more

WASHINGTON, June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that based on leading indicators and paid claims data t...

05 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

On June 5, 2025, the Board of Directors (the “Board”) of Evolent Health, Inc. (the “Company”) reconstituted the composition of the Audit Committee, the Compensation Committee, the Nominating and Governance Committee, the Compliance and R...

03 Jun 2025 8-K: Regulation FD Disclosure

As previously announced, on June 3, 2025, the management team of Evolent Health, Inc. (the “Company”) will present at the William Blair 45th Annual Growth Stock Conference at the Loews Hotel in Chicago, Illinois at 1:20pm CDT. As a remin...

08 May 2025 8-K: Results of Operations and Financial Condition

WASHINGTON (May 8, 2025) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and ...

22 Apr 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

WASHINGTON, April 22, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (“Evolent”), a company focused on achieving better health outcomes for people with complex conditions, today announced that a new director nominee will stand for...

20 Feb 2025 8-K: Results of Operations and Financial Condition

WASHINGTON (February 20, 2025) – Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simple...

04 Feb 2025 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

This Cooperation Agreement, dated as of February 3, 2025 (this “Agreement”), is by and among Evolent Health, Inc. (the “Company”) and the persons and entities set forth on Exhibit A hereto (the “Engaged Group,” and, for clarity and as ap...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support